Design of cyclic peptides with agonist activity at melanocortin receptor-4
- 1 July 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (14) , 3723-3726
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- New Substituted Piperazines as Ligands for Melanocortin Receptors. Correlation to the X-ray Structure of “THIQ”Journal of Medicinal Chemistry, 2004
- Phenylguanidines as Selective Nonpeptide Melanocortin-5 Receptor AntagonistsJournal of Medicinal Chemistry, 2004
- Synthesis and Structure−Activity Relationships of Novel Arylpiperazines as Potent and Selective Agonists of the Melanocortin Subtype-4 ReceptorJournal of Medicinal Chemistry, 2004
- Discovery of Tyrosine-Based Potent and Selective Melanocortin-1 Receptor Small-Molecule Agonists with Anti-inflammatory PropertiesJournal of Medicinal Chemistry, 2003
- Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor AgonistJournal of Medicinal Chemistry, 2002
- New aspects on the melanocortins and their receptorsPharmacological Research, 2000
- Functional Expression of the Human Acth Receptor GeneEndocrine Research, 2000
- Role of melanocortinergic neurons in feeding and the agouti obesity syndromeNature, 1997
- Potent and prolonged-acting cyclic lactam analogs of .alpha.-melanotropin: design based on molecular dynamicsJournal of Medicinal Chemistry, 1989
- Stimulation of Follicular Melanogenesis in the Mouse by Topical and Injected MelanotropinsJournal of Investigative Dermatology, 1987